BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 27462068)

  • 1. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.
    Al-Rasadi K; Al-Zakwani I; Alsheikh-Ali AA; Almahmeed W; Rashed W; Ridha M; Santos RD; Zubaid M
    J Clin Lipidol; 2018; 12(3):685-692.e2. PubMed ID: 29574074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program.
    Danchin N; Farnier M; Zeller M; Puymirat E; Cottin Y; Belle L; Lemesle G; Cayla G; Ohlmann P; Jacquemin L; Perret T; Angoulvant D; Albert F; Ferrières J; Schiele F; Simon T;
    J Clin Lipidol; 2020; 14(3):352-360.e6. PubMed ID: 32527469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
    Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
    J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.
    Klempfner R; Goldenberg I; Fisman EZ; Matetzky S; Amit U; Shemesh J; Tenenbaum A
    Am J Cardiol; 2014 Jan; 113(1):12-6. PubMed ID: 24157192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.
    Canivell S; Muller O; Gencer B; Heg D; Klingenberg R; Räber L; Carballo D; Matter C; Lüscher T; Windecker S; Mach F; Rodondi N; Nanchen D
    PLoS One; 2018; 13(4):e0195174. PubMed ID: 29649323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleeding.
    Nanchen D; Klingenberg R; Gencer B; Räber L; Carballo D; von Eckardstein A; Windecker S; Rodondi N; Lüscher TF; Mach F; Muller O; Matter CM
    Int J Cardiol; 2019 Jul; 287():13-18. PubMed ID: 31003794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prognostic value of echographic [corrected] risk score with the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry in Acute Coronary Events (GRACE) risk scores in acute coronary syndrome.
    Bedetti G; Gargani L; Sicari R; Gianfaldoni ML; Molinaro S; Picano E
    Am J Cardiol; 2010 Dec; 106(12):1709-16. PubMed ID: 21126614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome.
    Krasieva K; Gencer B; Locatelli I; Carballo D; Muller O; Fournier S; Matter CM; Räber L; Rodondi N; Mach F; Nanchen D
    Circ Cardiovasc Qual Outcomes; 2024 Jun; ():e010790. PubMed ID: 38899458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
    Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
    Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.